Literature DB >> 2200519

Kinetics of interaction of nucleotides with nucleotide-free H-ras p21.

J John1, R Sohmen, J Feuerstein, R Linke, A Wittinghofer, R S Goody.   

Abstract

A method is described for the convenient preparation of substantial quantities of nucleotide-free p21 or of 1:1 complexes with nucleotides other than GDP. The nucleotide-free protein has been used for kinetic studies of the binding of GDP and GTP, making use of the fluorescent analogues 3'-(methylanthraniloyl)-2'-deoxy-GDP and -GTP. Stopped-flow studies have led to the formulation of a two-step binding mechanism for both GDP and GTP, involving initial rapid but weak binding of the nucleotide followed by a relatively slow (10-20 s-1 at 25 degrees C; 3-5 s-1 at 5 degrees C) quasi-irreversible isomerization reaction. By use of a nonequilibrium competition method, guanosine and GMP have been shown to interact weakly but significantly with p21 (dissociation constants of 153 and 29 microM, respectively). The presence of guanosine or GMP at the active site of p21 leads to a marked stabilization of p21 against spontaneous denaturation when compared with the nucleotide- and nucleoside-free protein.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2200519     DOI: 10.1021/bi00477a025

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  121 in total

1.  Interaction of GTPase-activating protein with p21ras, measured using a continuous assay for inorganic phosphate release.

Authors:  M R Webb; J L Hunter
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

2.  Inhibition of NF-kappaB activity by IkappaBbeta in association with kappaB-Ras.

Authors:  Yi Chen; Sebastien Vallee; Joann Wu; Don Vu; John Sondek; Gourisankar Ghosh
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Spontaneous nucleotide exchange in low molecular weight GTPases by fluorescently labeled gamma-phosphate-linked GTP analogs.

Authors:  Jonas Korlach; Daniel W Baird; Ahmed A Heikal; Kyle R Gee; Gregory R Hoffman; Watt W Webb
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

4.  Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.

Authors:  Christine Bee; Anna Moshnikova; Christopher D Mellor; Justin E Molloy; Yulia Koryakina; Benjamin Stieglitz; Andrei Khokhlatchev; Christian Herrmann
Journal:  J Biol Chem       Date:  2010-03-25       Impact factor: 5.157

5.  Catalysis of GTP hydrolysis by small GTPases at atomic detail by integration of X-ray crystallography, experimental, and theoretical IR spectroscopy.

Authors:  Till Rudack; Sarah Jenrich; Sven Brucker; Ingrid R Vetter; Klaus Gerwert; Carsten Kötting
Journal:  J Biol Chem       Date:  2015-08-13       Impact factor: 5.157

6.  Intrinsic GTP hydrolysis is observed for a switch 1 variant of Cdc42 in the presence of a specific GTPase inhibitor.

Authors:  Kyla M Morris; Rory Henderson; Thallapuranam Krishnaswamy Suresh Kumar; Colin D Heyes; Paul D Adams
Journal:  Small GTPases       Date:  2016-02-01

7.  The signal recognition particle receptor of Escherichia coli (FtsY) has a nucleotide exchange factor built into the GTPase domain.

Authors:  C Moser; O Mol; R S Goody; I Sinning
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

8.  2'Halo-ATP and -GTP analogues: rational phasing tools for protein crystallography.

Authors:  M Gruen; C Becker; A Beste; J Reinstein; A J Scheidig; R S Goody
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

9.  The small GTPases K-Ras, N-Ras, and H-Ras have distinct biochemical properties determined by allosteric effects.

Authors:  Christian W Johnson; Derion Reid; Jillian A Parker; Shores Salter; Ryan Knihtila; Petr Kuzmic; Carla Mattos
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

Review 10.  Posttranslational Modifications of RAS Proteins.

Authors:  Ian Ahearn; Mo Zhou; Mark R Philips
Journal:  Cold Spring Harb Perspect Med       Date:  2018-11-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.